Reduced costs for Staphylococcus aureus carriers treated prophylactically with mupirocin and chlorhexidine in cardiothoracic and orthopaedic surgery.
BACKGROUND: A multi centre double-blind randomised-controlled trial (M-RCT), carried out in the Netherlands in 2005-2007, showed that hospitalised patients with S. aureus nasal carriage who were treated prophylactically with mupirocin nasal ointment and chlorhexidine gluconate medicated soap (MUP-CH...
Main Authors: | Miranda M L van Rijen, Lonneke G M Bode, Diane A Baak, Jan A J W Kluytmans, Margreet C Vos |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3419251?pdf=render |
Similar Items
-
IN VITRO ACTIVITY AND EMERGENCE OF RESISTANCE TO MUPIROCIN IN STAPHYLOCOCCUS AUREUS
by: Margalida Rotger, et al.
Published: (2003-10-01) -
Antibacterial Effect of Zinc Oxide Nanoparticles on Mupirocin-Resistant Staphylococcus aureus Isolated From Nasal Carriers
by: Afsaneh Hajimohammad, et al.
Published: (2018-06-01) -
Evaluation of mupirocin in the nasal decolonisation of methicillin resistant Staphylococcus aureus
by: Anyakwo, Andrew
Published: (2016) -
Preoperative Prevalence of Staphylococcus Aureus in Cardiothoracic and Neurological Surgical Patients
by: Ritu eKapoor, et al.
Published: (2014-11-01) -
MOLECULAR CHARACTERIZATION OF VANCOMYCIN, MUPIROCIN AND ANTISEPTIC RESISTANT STAPHYLOCOCCUS AUREUS STRAINS.
by: Mahtab Hadadi, et al.
Published: (2018-09-01)